Question-and-Answer SessionBut a lot going on at Neurocrine, Matt, can you give us a quick snapshot of the highlights of 2025 that we've passed or are yet to come.Matthew AbernethyChief Financial Officer Well, thanks, Josh, and we will be making forward-looking statements, so I'll get that out there. Yes, happy to be here. A lot going on for Neurocrine. And hopefully, this is Eric. We have an open chair here. A lot going on for Neurocrine. INGREZZA is going quite well, $2.5 billion in sales is what we expec ...